Royal Free Hospital, London
Hepatic intraarterial Y-90-DOTA-lanreotide deemed safe palliative treatment of liver metastases
Published in Women's Health Law Weekly, January 8th, 2006
Researchers in England conducted a study "to prospectively evaluate the safety and effectiveness of hepatic intraarterial injection of Y-90-DOTA-lanreotide as a treatment for patients with progressive large-volume somatostatin receptor-positive liver metastases from neuroendocrine tumors. The study was local ethics committee approved, and all patients gave informed consent. Twenty-three patients (13 men, 10 women; age range, 21-69 years; median age, 57 years) with histologically proved large-volume liver metastases from...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
More Articles from Women's Health Law Weekly
- Harvard Women's Health Watch
Article details how women can build hip bone strength, prevent injury - Howard Hughes Medical Institute
A new study shows that breast cancer drugs may slow the growth of lung cancer - Institute of Child Health, London
Antiretroviral therapy marginally affects early childhood growth - Karolinska Institute
Alcohol intake for women taking postmenopausal hormones may increase breast cancer risk - Medicare
Patient groups join effort to fix holes in healthcare efficiency
Integrating claims/clinical data may enhance cost estimates for cancer therapy- More from this issue of Women's Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
